390 related articles for article (PubMed ID: 32134973)
1. Illicit drug use while admitted to hospital: Patient and health care provider perspectives.
Strike C; Robinson S; Guta A; Tan DH; O'Leary B; Cooper C; Upshur R; Chan Carusone S
PLoS One; 2020; 15(3):e0229713. PubMed ID: 32134973
[TBL] [Abstract][Full Text] [Related]
2. Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs.
Ti L; Voon P; Dobrer S; Montaner J; Wood E; Kerr T
Pain Res Manag; 2015; 20(2):84-8. PubMed ID: 25562839
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings.
Rioux W; Kilby K; Jones S; Joshi P; Vandenberg S; Ghosh SM
Addict Sci Clin Pract; 2024 Jan; 19(1):4. PubMed ID: 38217056
[TBL] [Abstract][Full Text] [Related]
4. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.
McNeil R; Kerr T; Pauly B; Wood E; Small W
Addiction; 2016 Apr; 111(4):685-94. PubMed ID: 26498577
[TBL] [Abstract][Full Text] [Related]
5. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.
Bardwell G; Austin T; Maher L; Boyd J
Harm Reduct J; 2021 Mar; 18(1):29. PubMed ID: 33678163
[TBL] [Abstract][Full Text] [Related]
6. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
[TBL] [Abstract][Full Text] [Related]
7. End-of-life care in illicit drug users: mapping medication use.
Ulrick P; Panozzo S; Marco D; Collins A; Philip J
BMJ Support Palliat Care; 2023 Dec; 13(e2):e266-e269. PubMed ID: 34001548
[TBL] [Abstract][Full Text] [Related]
8. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
9. Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: A thematic framework analysis of coroner reports.
Lewer D; Brothers TD; Harris M; Rock KL; Copeland CS
PLoS One; 2023; 18(4):e0283549. PubMed ID: 37075021
[TBL] [Abstract][Full Text] [Related]
10. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
[TBL] [Abstract][Full Text] [Related]
11. "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use.
Behar E; Bagnulo R; Knight K; Santos GM; Coffin PO
PLoS One; 2020; 15(3):e0230408. PubMed ID: 32210442
[TBL] [Abstract][Full Text] [Related]
12. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada.
Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S
Harm Reduct J; 2022 Apr; 19(1):38. PubMed ID: 35436936
[TBL] [Abstract][Full Text] [Related]
13. Harm Reduction Services in Ottawa: The Culture of Drug Use.
Haines M; O'Byrne P
Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
[TBL] [Abstract][Full Text] [Related]
14. Perinatal Illicit Drug and Marijuana Use.
Chang JC; Holland CL; Tarr JA; Rubio D; Rodriguez KL; Kraemer KL; Day N; Arnold RM
Am J Health Promot; 2017 Jan; 31(1):35-42. PubMed ID: 26559718
[TBL] [Abstract][Full Text] [Related]
15. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
16. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
Newell S; Jordan Z
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
[TBL] [Abstract][Full Text] [Related]
17. Leaving the Hospital Against Medical Advice Among People Who Use Illicit Drugs: A Systematic Review.
Ti L; Ti L
Am J Public Health; 2015 Dec; 105(12):e53-9. PubMed ID: 26469651
[TBL] [Abstract][Full Text] [Related]
18. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.
Godersky ME; Saxon AJ; Merrill JO; Samet JH; Simoni JM; Tsui JI
Addict Sci Clin Pract; 2019 Mar; 14(1):11. PubMed ID: 30867068
[TBL] [Abstract][Full Text] [Related]
19. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
